Frontline PLC FRO
47.73
(0.24)
(0.50%)
as of 25 Sep
- Market cap
- $10.5B
- P/E
- 7.1×
Follow FRO
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
23.26 | 12.84 | 8.59 | 5.22 |
P/S ratio |
2.85 | 2.46 | 3.14 | 2.57 | |
P/FCF ratio |
7.93 | 6.87 | 5.33 | 4.58 | |
P/Operating CF |
47.43 | 17.14 | 20.30 | 13.37 | |
P/B ratio |
2.20 | 1.93 | 2.73 | 2.46 | |
Price to Tangible BV |
2.31 | 2.03 | 2.85 | 2.55 | |
EV/Sales |
4.55 | 3.89 | 4.01 | 3.27 | |
EV/EBITDA |
18.09 | 12.81 | 9.10 | 6.05 | |
EV/Operating CF |
14.38 | 11.24 | 10.71 | 7.29 | |
EV/FCF |
12.67 | 10.85 | 6.81 | 5.83 | |
Quick Ratio |
0.44 | 0.81 | 1.00 | 0.66 | |
Current Ratio |
1.37 | 1.43 | 2.03 | 1.87 | |
Net Debt/EBITDA |
31.76 | 10.13 | 3.69 | 3.15 | |
Debt/Assets |
56.73% | 53.32% | 46.44% | 41.89% | |
Debt/Equity |
1.39 | 1.22 | 0.93 | 0.77 | |
Asset Turnover |
0.30 | 0.33 | 0.42 | 0.51 | |
Operating CF/Net income |
2.67 | 1.24 | 0.68 | 0.88 | |
Capex/Depreciation |
0.00 | (0.02) | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
3.50% | 1.79% | 2.79% | 1.23% | |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.02 | |
Share Based Compensation of Revenue |
0.00% | 0.89% | 0.00% | 0.00% | |
Graham Net Nets |
(0.55) | (0.52) | (0.24) | (0.23) | |
Graham Number |
15.13 | 20.77 | 34.13 | 46.11 | |
Earnings Yield |
4.30% | 7.79% | 11.65% | 19.17% | |
Free Cash Flow Yield |
12.61% | 14.56% | 18.75% | 21.84% | |
Revenue per Share |
1.96 | 2.81 | 4.17 | 4.57 | |
Operating CF per Share |
0.48 | 1.27 | 1.72 | 2.60 | |
Capex per Share |
0.15 | (0.03) | 2.26 | (0.86) | |
Free Cash Flow per Share |
0.63 | 1.24 | 3.98 | 1.74 | |
Cash per Share |
0.86 | 1.14 | 2.12 | 1.45 | |
Shareholders Equity per Share |
10.38 | 11.28 | 12.75 | 14.17 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.38 | 11.28 | 12.75 | 14.17 | |
Free Cash Flow |
141.55 | 276.46 | 886.74 | 387.25 | |
Working Capital |
161.61 | 212.55 | 487.64 | 424.42 | |
Capital Expenditures |
33.91 | (6.89) | 504.25 | (192.24) | |
Net Current Asset Value |
(2,785.31) | (2,535.50) | (1,865.58) | (1,745.66) | |
EV/EBIT |
18.09 | 12.81 | 9.10 | 6.05 | |
Capex to Sales |
(0.08) | 0.01 | (0.54) | 0.19 | |
Net Profit Margin |
9.19% | 36.50% | 60.16% | 64.71% | |
Price to Operating Income |
11.33 | 8.11 | 7.12 | 4.75 | |
| Other line items | |||||
Average Receivables |
— | 116.15 | — | — | |
Average Payables |
— | 93.24 | — | — | |
Average Inventory |
— | 100.43 | — | — | |
Average Assets |
5,996.99 | 5,987.22 | 5,901.94 | 5,961.13 | |
Average Common Equity |
2,336.59 | 2,425.53 | 2,584.81 | 2,760.45 |
Columns are period end dates